Literature DB >> 19399380

[Linear IgA disease with ocular involvement associated with ulcerative colitis].

A Klein1, S M Wenzel, E M Messmer, M Landthaler, T Vogt.   

Abstract

The association of linear IgA disease (LAD), ulcerative colitis and scarring ocular involvement is very rare and represents a considerable therapeutic challenge. We report a 48-year-old male diagnosed with ulcerative colitis in 1995, who received long-term methylprednisolone therapy. Later, he developed ocular inflammation with conjunctival scarring and synechiae formation as well as episodes of vesicles. Although azathioprine was added to his regimen, the disease was not controlled. After the diagnosis of LAD was established, dapsone was added. With this therapy, the ocular inflammation decreased significantly and the methylprednisolone dose could be successfully tapered slowly without reappearance of vesicles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19399380     DOI: 10.1007/s00105-009-1737-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

1.  Ocular linear IgA disease resulting in blindness.

Authors:  Carolina Talhari; Christoph Althaus; Mosaad Megahed
Journal:  Arch Dermatol       Date:  2006-06

2.  Linear IgA disease and ulcerative colitis.

Authors:  D G Paige; J N Leonard; F Wojnarowska; L Fry
Journal:  Br J Dermatol       Date:  1997-05       Impact factor: 9.302

3.  Linear IgA disease and ulcerative colitis.

Authors:  C De Simone; C Guerriero; R Pellicano
Journal:  Eur J Dermatol       Date:  1998 Jan-Feb       Impact factor: 3.328

4.  Linear IgA disease.

Authors:  J R Smith; A Kupa; D J Coster
Journal:  Aust N Z J Ophthalmol       Date:  1999-12

5.  Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany.

Authors:  D Zillikens; S Wever; A Roth; B Weidenthaler-Barth; T Hashimoto; E B Bröcker
Journal:  Arch Dermatol       Date:  1995-08

6.  Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy.

Authors:  E Letko; K Bhol; C S Foster; A R Ahmed
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

Review 7.  Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.

Authors:  M A Waldman; D R Black; J P Callen
Journal:  Clin Exp Dermatol       Date:  2004-11       Impact factor: 3.470

8.  Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease.

Authors:  A Lally; A Chamberlain; J Allen; D Dean; F Wojnarowska
Journal:  Clin Exp Dermatol       Date:  2007-04-24       Impact factor: 3.470

9.  Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis.

Authors:  V C Thoree; S J C Golby; L Boursier; M Hackett; D K Dunn-Walters; J D Sanderson; J Spencer
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.

Authors:  P Bernard; L Vaillant; B Labeille; C Bedane; B Arbeille; J P Denoeux; G Lorette; J M Bonnetblanc; C Prost
Journal:  Arch Dermatol       Date:  1995-01
View more
  1 in total

1.  Linear IgA dermatosis associated with ulcerative colitis: complete and sustained remission after total colectomy.

Authors:  Thiago Jeunon de Sousa Vargas; Mônica Fialho; Luiza Tavares dos Santos; Palmira Assis de Jesus Barreto Rodrigues; Ana Luisa Bittencourt Sampaio Jeunon Vargas; Maria Auxiliadora Jeunon Sousa
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.